Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
Maruto Sangyo, 15% Increase in Ordinary Profit for The Current Fiscal Year
7894 Maruto Sangyo Co., Ltd. 【J-GAAP】
Earnings ReportMaruto Sangyo Co., Ltd. <7894> [FSE] announced its financial results after the market closed on April 14th (15:30). The consolidated ordinary profit for the fiscal year ending February 2025 decreased 24.9% from the previous period to 404 million yen. In the fiscal year ending February 2026, the profit is expected to grow by 15.1% to 465 million yen.
In the most recent three-month period, from December to February (4Q), the consolidated ordinary profit grew 25.2% from the same period last year, reaching 139 million yen. The operating profit margin improved from 2.1% in the same period last year to 3.0%.
Kabutan News
Actual Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Feb, 2023 | 18,136 | 480 | 611 | 416 | 262.6 | 40 | Apr 12, 2023 | J-GAAP |
Feb, 2024 | 17,853 | 418 | 538 | 366 | 231.2 | 40 | Apr 15, 2024 | J-GAAP |
Feb, 2025 | 18,046 | 336 | 404 | 296 | 186.6 | 40 | Apr 14, 2025 | J-GAAP |
YoY | +1.1% | -19.6% | -24.9% | -19.1% | -19.3% |
Full Year Results vs. Previous Guidance
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Feb, 2025 Guidance | 18,600 | 430 | 490 | 370 | 233.1 | 40 | Apr 15, 2024 | J-GAAP |
Feb, 2025 Results | 18,046 | 336 | 404 | 296 | 186.6 | 40 | Apr 14, 2025 | J-GAAP |
Revision Rate | -3.0% | -21.9% | -17.6% | -20.0% | -19.9% |
Current Period Guidance
H1 Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Mar - Aug, 2024 | 8,720 | 101 | 177 | 156 | 98.5 | 0 | Oct 15, 2024 | J-GAAP |
Mar - Aug, 2025 Guidance | ー | ー | ー | ー | - | 0 | Apr 14, 2025 | J-GAAP |
YoY | - | - | - | - | - |
Current Period Guidance
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Feb, 2024 | 17,853 | 418 | 538 | 366 | 231.2 | 40 | Apr 15, 2024 | J-GAAP |
Feb, 2025 | 18,046 | 336 | 404 | 296 | 186.6 | 40 | Apr 14, 2025 | J-GAAP |
Feb, 2026 Guidance | 18,800 | 415 | 465 | 355 | 223.7 | 40 | Apr 14, 2025 | J-GAAP |
YoY | +4.2% | +23.5% | +15.1% | +19.9% | +19.9% |
Quarterly Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Dec - Feb, 2023 | 4,272 | 88 | 111 | 64 | 40.4 | 2.1 | Apr 15, 2024 | J-GAAP |
Mar - May, 2024 | 4,283 | 39 | 107 | 100 | 63.6 | 0.9 | Jul 16, 2024 | J-GAAP |
Jun - Aug, 2024 | 4,437 | 62 | 70 | 56 | 35.4 | 1.4 | Oct 15, 2024 | J-GAAP |
Sep - Nov, 2024 | 4,460 | 91 | 88 | 49 | 30.9 | 2.0 | Jan 14, 2025 | J-GAAP |
Dec - Feb, 2024 | 4,866 | 144 | 139 | 91 | 57.4 | 3.0 | Apr 14, 2025 | J-GAAP |
YoY | +13.9% | +63.6% | +25.2% | +42.2% | +41.9% |
Related Articles
COSMOS Pharma, Jun-Feb (Cumulative 3Q) Ordinary Profit Increases by 30%, Dec-Feb Ordinary Profit Increases by 40%
FP Partner, Dec-Feb (1Q) Ordinary Profit Decreases by 42%
DIP, 10% Decrease in Ordinary Profit for The Current Fiscal Year
Totenko, 2% Increase in Ordinary Profit for The Current Fiscal Year
Asterisk, The Current Fiscal Year Ordinary Profit Revised Downward by 82%
VALUE CREATION, 50% Increase in Ordinary Profit, Record High for The First Time in Two Years, Dividend Raised by 0.5 yen
Daito Pharma, The Current Fiscal Year Ordinary Profit Revised Downward by 26%
KAWAKAMI PAINT, Dec-Feb (1Q) Ordinary Profit Turns to Loss
AFC-HD AMS Life Science, First Half Ordinary Profit Increases by 26%, Dec-Feb Ordinary Profit Increases by 10%
Life Foods, 52% Decrease in Ordinary Profit for The Current Fiscal Year, Resuming Dividends at 5 yen for the First Time in five terms., Plan to Continue the 5 yen Policy This Fiscal Year as Well